(Q48248462)

9 February 2018

title

Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal (English)

1 reference

9 February 2018

0 references

1 reference

1

1 reference

9 February 2018

author name string

Muntoni AL

2

1 reference

9 February 2018

Pistis M

3

1 reference

9 February 2018

Melis M

4

1 reference

9 February 2018

Gessa GL

5

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

9 February 2018

European Journal of Neuroscience

published in

1 reference

9 February 2018

volume

11

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

1037-1041

1 reference

9 February 2018

Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Anatomically distinct opiate receptor fields mediate reward and physical dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Mesolimbic dopaminergic decline after cannabinoid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: evidence of protracted abstinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Cellular mechanisms of behavioral sensitization to drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Anesthetic influences on the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Cellular and molecular mechanisms of drug dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Drug abuse: hedonic homeostatic dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Drug addiction: a model for the molecular basis of neural plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Changes in response rates and reinforcement thresholds for intracranial self-stimulation during morphine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Synaptic regulation of mesocorticolimbic dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Chronic administration of morphine decreases level of dynorphin A in the rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

Dark side of drug dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1999.00488.X

10.1046/J.1460-9568.1999.00488.X

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018